Kevin J. Yeaman - 05 Feb 2026 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
09 Feb 2026, 16:19:17 UTC
Prior SEC filing
17 Dec 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Daniel Rodriguez as Attorney-in-Fact for Kevin Yeaman

Key filing fact

Kevin J. Yeaman filed Form 4 for Dolby Laboratories, Inc. (DLB) on 09 Feb 2026.

Key facts

  • This page summarizes Kevin J. Yeaman's Form 4 filing for Dolby Laboratories, Inc. (DLB).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 09 Feb 2026, 16:19.

Change

  • Previous filing in this sequence was filed on 17 Dec 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001200469 Primary reporting owner

YEAMAN KEVIN J

Relationship
President and CEO, Director
Address
C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO
Signature
/s/ Daniel Rodriguez as Attorney-in-Fact for Kevin Yeaman
Signature date
09 Feb 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DLB transaction Derivative

Employee Stock Option (Right to Buy)

Gift

Transaction value
$0
Shares
-145,252
Change %
-50%
Price
$0.000000
Shares after
145,252
Date
05 Feb 2026
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
145,252
Exercise price
$66.62
Footnotes
F1, F2
DLB transaction Derivative

Employee Stock Option (Right to Buy)

Gift

Transaction value
$0
Shares
+145,252
Change %
Price
$0.000000
Shares after
145,252
Date
05 Feb 2026
Ownership
By a trust
Underlying class
Class A Common Stock
Underlying amount
145,252
Exercise price
$66.62
Footnotes
F1, F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Effective February 5, 2026, the Reporting Person transferred this option to a revocable trust for no consideration, for estate planning purposes. This transfer is exempt from Section 16(b) by virtue of Rule 16b-5.

Footnote F2

This option was granted for a total of 145,252 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2025, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter.

Footnote F3

By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .